PAM
NGNE icon

Panagora Asset Management’s Neurogene NGNE Stock Holding History

Panagora Asset Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-120
Closed -$29K – 2898
2020
Q3 		$29K Buy
+120
New +$29.1K ﹤0.01% 2126
2019
Q1 		– Sell
-2,230
Closed -$96K – 2546
2018
Q4 		$96K Buy
+2,230
New +$109K ﹤0.01% 1819
2018
Q3 		– Sell
-2,191
Closed -$116K – 2451
2018
Q2 		$116K Buy
+2,191
New +$571K ﹤0.01% 1807
2016
Q1 		– Sell
-200
Closed -$50K – 2323
2015
Q4 		$50K Buy
+200
New +$52.6K ﹤0.01% 1981

Other funds holding NGNE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Panagora Asset Management's NGNE Position: Q4 2020 in Review

Panagora Asset Management sold out of Neurogene (NGNE) in Q4 2020, closing a stake of 120 shares — an estimated $29K sold.

Panagora Asset Management first reported a position in NGNE in Q4 2015 and held it in 4 quarters. The position peaked at $116K in Q2 2018. 84 funds tracked by Wall St. Rank hold NGNE as of Q4 2020.

  • Panagora Asset Management reported no remaining Neurogene position as of Q4 2020 after selling out during the quarter.
  • Panagora Asset Management sold 120 Neurogene shares in Q4 2020, an estimated $29K.
  • Panagora Asset Management first reported a position in Neurogene in Q4 2015 and held it in 4 quarters.
  • Panagora Asset Management's Neurogene position peaked at $116K in Q2 2018.
  • 84 funds tracked by Wall St. Rank held Neurogene as of Q4 2020.

Based on Panagora Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.